FDA Moves to End GRAS Self-Affirmation: What Mandatory GRAS Notification Means for Importers and Manufacturers

On August 11, 2026, the U.S. Food and Drug Administration published one of the most consequential food-ingredient proposals in decades. The proposed rule would end a long-standing practice that has allowed companies to introduce new substances into the American food supply without ever telling the FDA. For businesses that import, manufacture, or source food ingredients, this is a change worth understanding early — because when it takes effect, it will reshape how new ingredients are documented, submitted, and defended. And with the public comment period closing on December 9, 2026, the window to weigh in is closing fast.

Here is a plain-language breakdown of what the FDA is proposing, why it matters, and what companies in the food supply chain should be doing now.

The Background: What “GRAS” Actually Means

“GRAS” stands for Generally Recognized as Safe. It is a category in U.S. food law for substances that qualified experts agree are safe for their intended use, based on either a long history of use in food or published scientific evidence. Common ingredients like vinegar, salt, and many spices fall under this umbrella. The GRAS concept exists so that companies don’t have to seek formal FDA approval for every ordinary, well-established ingredient.

Under the current system, a company can independently conclude that an ingredient is GRAS — often called a “self-affirmed” or self-determined GRAS conclusion — and bring it to market without notifying the FDA and without proactively handing over the safety evidence behind that decision. Notifying the FDA has been entirely voluntary.

What the Proposed Rule Would Change

The proposal, which would amend 21 CFR Parts 170 and 570, would make GRAS notification mandatory rather than voluntary.

The core requirements break down as follows:

Notification becomes required, not optional. Any company that concludes a substance is GRAS — whether for a brand-new ingredient or a new use of an existing one — would have to notify the FDA and lay out the basis for that conclusion. This applies to direct food additives as well as indirect substances, such as chemicals that migrate into food from packaging.

It covers both human and animal food. The rule reaches any person introducing a substance into interstate commerce under the GRAS provision for use in human or animal food, so pet food and livestock feed suppliers are squarely within scope.

It is not a pre-market approval program — but the distinction is nuanced. Importantly, companies would still be allowed to market a substance while the FDA reviews the notification. The FDA would have 45 days to file a submission and generally 180 days (with a possible 90-day extension) to respond. That said, industry experts have noted that this “not pre-market approval” framing has limits: if the FDA ultimately disagrees with a company’s GRAS determination, the practical result could be products being pulled from the market.

There is a streamlined path for ingredients already in commerce. For substances that were already on the market before the rule’s effective date, the FDA proposes a lighter-touch submission. Rather than a full GRAS notice up front, a company could provide basic information — the substance, its intended uses and use levels, and evidence that it was already in interstate commerce.

The Timeline You Need to Know

For planning purposes, these are the dates that matter:

• Public comment period closes December 9, 2026. The mandatory GRAS notifiction proposed rule opened for a 120-day public comment period following its August 11, 2026 Federal Register publication, and comments are due by December 9, 2026. The FDA has emphasized this is a “blueprint” for gathering input, not a finished rule — and that window is now closing. The agency also held a public webinar on October 15, 2026 walking through the proposal; a recording is available on the FDA’s website.
• 60 days to take effect. If finalized, the rule would become effective 60 days after the final version is published.
• 18-month compliance runway. Companies would then have 18 months after the effective date to come into compliance.

Why This Matters for Importers and Food Businesses

For companies that import ingredients or finished food products, source novel ingredients, or manufacture using specialty additives, mandatory GRAS notification will impact operations.

Documentation becomes a business-critical asset. Today, a self-affirmed GRAS conclusion might live in a binder or a supplier’s files. Under the proposed rule, the safety basis behind each GRAS ingredient needs to be complete, current, and ready to submit to the FDA. Companies that have relied on suppliers’ assurances will want to confirm that the underlying evidence actually exists and holds up.

Supply-chain visibility becomes non-negotiable. Importers frequently sit between foreign manufacturers and U.S. buyers. If an ingredient in a sourced product depends on a GRAS conclusion, the party introducing that substance into U.S. commerce needs to be identified and prepared to meet the notification requirement. This is a good moment to map which ingredients in your catalog rely on GRAS status and who is responsible for the underlying determination.

Timelines for new ingredient launches may lengthen. The FDA currently receives roughly 50 voluntary GRAS submissions a year. Under a mandatory system, that number could climb into the hundreds or even thousands. More submissions could strain FDA review capacity and extend the timeline for bringing new ingredients to market. Companies planning product launches around novel ingredients should build in additional lead time.

Transparency can be a competitive advantage. The broader policy push — part of the current administration’s food-transparency agenda — reflects growing consumer and regulator interest in knowing exactly what is in food. Businesses that get ahead of the documentation curve won’t just be compliant; they’ll be positioned to answer the “what’s in it and is it safe?” question with confidence.

What to Do Now

While the rule is not yet final, there are sensible, low-regret steps to take during the comment period:

1. Inventory your GRAS-dependent ingredients. Identify every substance in your products that relies on a GRAS conclusion — self-affirmed or otherwise — and note which are already in interstate commerce (and therefore may qualify for the streamlined path).
2. Verify the safety basis behind each one. Confirm that the scientific evidence or history-of-use documentation supporting each GRAS conclusion is complete and defensible, not just assumed.
3. Talk to your suppliers. For imported and sourced ingredients, clarify who holds the GRAS determination and who will bear the notification obligation.
4. Consider submitting a comment before December 9, 2026. Because this is still a proposal, affected businesses have a direct opportunity to shape the final rule — but only until the comment period closes on December 9. Comments can be filed through Regulations.gov under docket number FDA-2025-N-3262. Practical concerns about timelines, streamlined submissions, and the treatment of imported ingredients are exactly the kind of input the FDA is soliciting.
5. Build the compliance runway into your roadmap. An 18-month compliance window sounds generous until you multiply it across a large ingredient portfolio. Start scoping the work now.

How USFI Can Help

Navigating shifting food-safety regulation is part of what we do every day. As these requirements take shape, US Food Imports can help you understand how the rule affects your specific product lines, work with your suppliers to confirm ingredient documentation, and keep your sourcing decisions aligned with where U.S. food policy is heading. If you have questions about how mandatory GRAS notification could affect your imports or product formulations, reach out — we’re happy to walk through it with you.

This post is intended as general information about a proposed FDA rule and does not constitute legal or regulatory compliance advice. Because the rule is still in the comment period, its final requirements may change. Consult qualified regulatory counsel for guidance specific to your business.

---